SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-036210
Filing Date
2023-11-02
Accepted
2023-11-02 07:44:21
Documents
14
Period of Report
2023-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lnth-20231102.htm   iXBRL 8-K 28430
2 EX-99.1 exhibit991q32023earningspr.htm EX-99.1 246041
6 newlantheuslogo.jpg GRAPHIC 3408
  Complete submission text file 0001628280-23-036210.txt   422391

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20231102.xsd EX-101.SCH 1904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20231102_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20231102_pre.xml EX-101.PRE 12510
8 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20231102_htm.xml XML 2735
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 231370122
SIC: 2835 In Vitro & In Vivo Diagnostic Substances